MedTech Business - March 2, 2026
SciBase receives FDA approval for extended labelling in the US
The company has received approval by FDA for its supplement to extend the labelling to include other healthcare professionals and not only dermatologists to perform the Nevisense procedure.
CDMO - March 1, 2026
A journey of discovery at NorthX Biologics
When His Royal Highness Prince Daniel and visitors from the Royal Swedish Academy of Engineering Sciences visited NorthX Biologics up in Matfors in northern Sweden, the company chose a somewhat different approach.
Intellectual Property - February 25, 2026
Salipro Biotech obtains key US patent grant
The new patent secures long term protection for the Salipro platform technologies, extending exclusivity until 2042 and reinforcing the company’s position as a premier partner for drug discovery against challenging drug targets.
Biotech Business - February 25, 2026
Hansa Biopharma’s BLA for imlifidase accepted by the FDA
The company's Biologics License Application (BLA) for imlifidase has been accepted by the U.S. Food and Drug Administration (FDA).
Biotech Business - February 24, 2026
AAX Biotech secures investment from Trio Impact Invest
The investment supports the continued development and scaling of the company’s antibody technology platforms, enabling expanded application areas and strengthened industry collaborations.
Financing - February 24, 2026
Oncopeptides carries out a rights issue of approx SEK 200 million
The Board of Directors has resolved to carry out a new share issue of approximately SEK 200 million with preferential rights for the company’s existing shareholders based on the authorization granted by the Annual General Meeting on 22 May 2025.
